Human Plasma Fractionation industry
Shear sensitive, gentle, cost conscious processing
Recombiant biopharma products
Rapid development, safe and robust
Generics and transgenics
Fast and cost conscious processing
Functional food industry
Easy, linear scalable to industrial size
Posted: October 15, 2018
Proxcys staat in de finale van Drentse Onderneming van het Jaar!
Afgelopen donderdag heeft Anita Oosterveld-Janssen Proxcys vertegenwoordigd tijdens de halve finale in Borger.
Wij zijn enorm trots dat wij samen met Vepa en New Nexus mogen strijden om de titel:
Drentse onderneming van het jaar 2018.
Op 15 november zal de winnaar worden verkozen tijdens een feestelijke bijeenkomst in het Atlas Theater in Emmen.
Posted: October 14, 2018
Transition to ISO 9001-2015 of Proxcys organisation successfully completed!
Lloyds auditor quoted:
- Proxcys BV has succesfully paired a steady growth in turnover, product range, product support & customization and fame, creating a strong market position.
- The team expresses a distinctive commitment, highly focussing on the client-support and bespoke product development while optimising the internal process control.
- The sound approach creates a stable work environment for the employees and reflects positively to their suppliers.
Posted: July 05, 2018
PROXCYS Downstream Biosystems
The world's primary producer of High Performance Radial Flow Chromatography (HP-RFC) equipment. PROXCYS is dedicated to develop and build cGMP purification equipment that will help to reduce the cost of life saving therapeutics.
Sustainable and industrial impact
Operational and process advantages
Radial Chromatography equipment
More than a decade the unique proprietary Annular HP-RFC columns and systems help to provide column efficiency, symmetry and packed bed stability, applied in cGMP compliant purification of biologicals from various sources like Human blood plasma, cell culture, fermentation, homogenates or milk.
A large array of columns and systems cover all scales of operation, from lab bench to industrial size.